Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes: A Substudy From the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial.

Link to article at PubMed

Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes: A Substudy From the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial.

Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):680-688

Authors: Husted S, James S, Becker RC, Horrow J, Katus H, Storey RF, Cannon CP, Heras M, Lopes RD, Morais J, Mahaffey KW, Bach RG, Wojdyla D, Wallentin L, for the PLATO study group

Abstract



Background- Elderly patients with acute coronary syndrome are at high risk of recurrent ischemic events and death, and for both antithrombotic therapy and catheter-based complications. This prespecified analysis investigates the effect and treatment-related complications of ticagrelor versus clopidogrel in elderly patients (?75 years of age) with acute coronary syndrome compared with those http://www.clinicaltrials.gov. Unique identifier: NCT00391872.

PMID: 22991347 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *